[1]
A. F. Monteiro, M. Rato, and C. Martins, “Vemurafenib-Induced Toxic Epidermal Necrolysis: An Emerging Adverse Event”, SPDV, vol. 76, no. 3, pp. 329-332, Oct. 2018.